IIM
PRME icon

INTECH Investment Management’s Prime Medicine PRME Stock Holding History

INTECH Investment Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
30,538
-4,498
-13% -$17.1K ﹤0.01% 1884
2025
Q4 		$122K Buy
35,036
+11,808
+51% +$52.5K ﹤0.01% 2113
2025
Q3 		$129K Sell
23,228
-7,582
-25% -$30.8K ﹤0.01% 2199
2025
Q2 		$76.1K Sell
30,810
-24,136
-44% -$37.2K ﹤0.01% 2354
2025
Q1 		$109K Buy
54,946
+24,542
+81% +$62.6K ﹤0.01% 2293
2024
Q4 		$88.8K Buy
30,404
+16,302
+116% +$57.2K ﹤0.01% 2236
2024
Q3 		$54.6K Buy
+14,102
New +$65.3K ﹤0.01% 1975

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

INTECH Investment Management's PRME Position: Q1 2026 in Review

INTECH Investment Management reduced its Prime Medicine (PRME) stake by 13% in Q1 2026, selling an estimated $17.1K and leaving 30,538 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1884.

INTECH Investment Management first reported a position in PRME in Q3 2024 and has held it in 7 quarters since. The position peaked at $129K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • INTECH Investment Management held 30,538 shares of Prime Medicine worth $106K as of Q1 2026.
  • INTECH Investment Management sold 4,498 Prime Medicine shares in Q1 2026, an estimated $17.1K.
  • Prime Medicine made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1884 holding.
  • INTECH Investment Management first reported a position in Prime Medicine in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Prime Medicine position peaked at $129K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.